Castle Biosciences (CSTL) Analyst & Key Data

Analyst Consensus

Buy11 analysts

Buy

Updated Sep 12, 2026

Total Analysts11

Buy

11

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$32.33

Median Target+36.93%

$44.27

Potential upside vs current price

Current Stock Price

$32.33

Median Target+36.93%

$44.27

Potential upside vs current price

Analyst Consensus

Buy11 analysts

Buy

Updated Sep 12, 2026

Total Analysts11

Buy

11

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$32.33

Median Target+36.93%

$44.27

Potential upside vs current price

Current Stock Price

$32.33

Median Target+36.93%

$44.27

Potential upside vs current price

Castle Biosciences, Inc.